Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00993759Phase 2Unknown
A Phase 2 trial of 3804-250A in common cold, rhinovirus infection, sponsored by Dial Pharmaceuticals. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00993759.